IL142639A0 - Surfactant protein d for the prevention and diagnosis of pulmonary emphysema - Google Patents

Surfactant protein d for the prevention and diagnosis of pulmonary emphysema

Info

Publication number
IL142639A0
IL142639A0 IL14263999A IL14263999A IL142639A0 IL 142639 A0 IL142639 A0 IL 142639A0 IL 14263999 A IL14263999 A IL 14263999A IL 14263999 A IL14263999 A IL 14263999A IL 142639 A0 IL142639 A0 IL 142639A0
Authority
IL
Israel
Prior art keywords
emphysema
diagnosis
protein
surfactant protein
prevention
Prior art date
Application number
IL14263999A
Other languages
English (en)
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Publication of IL142639A0 publication Critical patent/IL142639A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14263999A 1998-10-20 1999-10-20 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema IL142639A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10494198P 1998-10-20 1998-10-20
PCT/US1999/024675 WO2000023569A1 (en) 1998-10-20 1999-10-20 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema

Publications (1)

Publication Number Publication Date
IL142639A0 true IL142639A0 (en) 2002-03-10

Family

ID=22303258

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14263999A IL142639A0 (en) 1998-10-20 1999-10-20 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
IL142639A IL142639A (en) 1998-10-20 2001-04-17 Use of an isolated mammalian sp-d protein or vectors expressing said protein for manufacturing an aerosol formulation for treating emphysema

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142639A IL142639A (en) 1998-10-20 2001-04-17 Use of an isolated mammalian sp-d protein or vectors expressing said protein for manufacturing an aerosol formulation for treating emphysema

Country Status (11)

Country Link
EP (2) EP1995315B1 (de)
JP (1) JP4807902B2 (de)
AT (1) ATE402255T1 (de)
AU (1) AU767774B2 (de)
BR (1) BR9914645A (de)
CA (2) CA2347248C (de)
DE (1) DE69939179D1 (de)
DK (1) DK1995315T3 (de)
ES (2) ES2488692T3 (de)
IL (2) IL142639A0 (de)
WO (1) WO2000023569A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838428B2 (en) * 1998-10-20 2005-01-04 Children's Hospital Medical Center Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US20030221199A1 (en) * 1998-10-20 2003-11-27 Whitsett Jeffrey A. Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
DK1440083T3 (da) 2001-10-25 2013-03-25 Medical Res Council Molekyler
WO2003084476A2 (en) * 2002-04-01 2003-10-16 Gtc Biotherapeutics, Inc. Treatment of lung disorder
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
JP5048678B2 (ja) * 2005-11-03 2012-10-17 チルドレンズ ホスピタル メディカル センター 肺感染症および敗血症を防止および処置するための表面活性タンパク質−d
US8883730B2 (en) * 2006-09-29 2014-11-11 Council Of Scientific And Industrial Research Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic bosinophils
GB201402909D0 (en) 2014-02-19 2014-04-02 Univ Southampton Treating infection
WO2016199146A1 (en) 2015-06-09 2016-12-15 B. G. Negev Technologies And Applications Ltd A controlled release system for pulmonary delivery of surfactant protein d

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0482097T3 (da) * 1989-07-11 2001-09-17 Genentech Inc Tensidpræparater og fremgangsmåder
JPH09500782A (ja) * 1993-04-08 1997-01-28 ジェネティック セラピー,インコーポレイテッド 肺界面活性タンパク質をコード化するdnaを含むアデノウイルスベクター

Also Published As

Publication number Publication date
CA2347248A1 (en) 2000-04-27
CA2749553A1 (en) 2000-04-27
EP1123383A1 (de) 2001-08-16
EP1995315A3 (de) 2010-06-23
EP1123383B1 (de) 2008-07-23
EP1123383A4 (de) 2002-07-17
EP1995315B1 (de) 2014-05-14
EP1995315A2 (de) 2008-11-26
CA2347248C (en) 2011-09-20
BR9914645A (pt) 2002-02-05
WO2000023569A1 (en) 2000-04-27
ES2488692T3 (es) 2014-08-28
WO2000023569A9 (en) 2002-08-29
DK1995315T3 (da) 2014-07-28
AU767774B2 (en) 2003-11-27
DE69939179D1 (de) 2008-09-04
IL142639A (en) 2009-09-01
WO2000023569A8 (en) 2003-11-06
JP4807902B2 (ja) 2011-11-02
ES2311307T3 (es) 2009-02-01
JP2002527102A (ja) 2002-08-27
CA2749553C (en) 2015-09-15
ATE402255T1 (de) 2008-08-15
AU1598000A (en) 2000-05-08

Similar Documents

Publication Publication Date Title
AU5738601A (en) Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
WO2003038058A3 (en) Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
IL142639A0 (en) Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
WO2002078524A3 (en) Translational profiling
Hatada et al. Identification of a new imprinted gene, Rian, on mouse chromosome 12 by fluorescent differential display screening
ATE420198T1 (de) Methylotrophe hefe,die eine zuckerkette eines säugers herstellt
ATE117373T1 (de) Herstellung von guar-alpha-galactosidase mit durch rekombinante dns-verfahren transformierten wirtzellen.
ATE486935T1 (de) Mikroorganismenstamm zur produktion von rekombinanten proteinen
CN112111471A (zh) 广谱识别PAM序列的FnCpf1突变体及其应用
EP1534835A4 (de) Yapsin-mangelmutantenstamm von hansenula polymorpha sowie verfahren zur herstellung rekombinanter proteine damit
Goyal et al. Fractionation of Leuconostoc mesenteroides NRRL B-512F dextran sucrase by polyethylene glycol: A simple and effective method purification
JPH08509865A (ja) 耐熱性α1−抗トリプシンムテイン
AU762048B2 (en) Allelic series of genomic modifications in cells
CN107868781A (zh) 人工合成mar片段、表达载体、表达系统及其应用
Ge et al. Differential susceptibility of transgenic mice expressing human surfactant protein B genetic variants to Pseudomonas aeruginosa induced pneumonia
DK1383890T3 (da) Deoxycytidinkinase-mutanter med udvidet enzymaktivitet
JP2008109867A5 (de)
CN115992203A (zh) 一种全基因组羟甲基化捕获测序的文库构建方法
CN115305248A (zh) 一种睾丸内myh11基因敲除小鼠模型的构建方法及其应用
JP2636844B2 (ja) 酵母の外質隙中に局在するポリペプチドの回収法
BR9916172A (pt) Meios e processos para influenciar o comportamento de floração de plantas
DK1472347T3 (da) Forbedret proteinekspression i Bacillus Subtilis
Di Maro et al. Primary structure of superoxide dismutase from Pseudoalteromonas haloplanktis by a combination of automatic Edman degradation and ESI/Q-TOF mass spectrometry
De Grove et al. Role Of Chemr23 Signaling In Diesel-Enhanced Allergic Airway Inflammation
Guohua Improvement of Xylanase Activity by Error-prone PCR